| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/AJMG.B.20007 |
| P698 | PubMed publication ID | 12707932 |
| P50 | author | Marion Leboyer | Q28444907 |
| Marie-Odile Krebs | Q47503005 | ||
| Andrei Szöke | Q57477771 | ||
| Franck Schürhoff | Q83120264 | ||
| P2093 | author name string | Frédéric Rouillon | |
| Jean-Louis Laplanche | |||
| Jean Tignol | |||
| Jean-Yves Loze | |||
| Céline Goldberger | |||
| Valérie Quignon | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex | Q28138248 | ||
| Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease | Q28238269 | ||
| Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| On estimating the relation between blood group and disease | Q34261825 | ||
| Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative | Q34324588 | ||
| Alzheimer-type neuropathology in elderly schizophrenia patients | Q40812165 | ||
| The genetics of schizophrenia: a current, genetic-epidemiologic perspective | Q40821125 | ||
| The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia | Q40834511 | ||
| Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides | Q41172424 | ||
| Free radical pathology and antioxidant defense in schizophrenia: a review | Q41468133 | ||
| Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients | Q43892563 | ||
| Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. | Q44092789 | ||
| Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease | Q45025377 | ||
| Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro | Q45081026 | ||
| Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition | Q48745613 | ||
| Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. | Q52010922 | ||
| The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. | Q52021940 | ||
| Apolipoprotein E genotype in Spanish schizophrenic patients. | Q53237709 | ||
| No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. | Q53329779 | ||
| Apolipoprotein E ɛ4 and clinical phenotype in schizophrenia | Q57655653 | ||
| Apolipoprotein E type ϵ4 allele frequency is increased in patients with schizophrenia | Q60620885 | ||
| Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins | Q68921833 | ||
| Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population | Q71123766 | ||
| Apolipoprotein E genotype in schizophrenia | Q71300945 | ||
| Apolipoprotein E-varepsilon4 frequency in deficit schizophrenia | Q73206055 | ||
| Apolipoprotein E genotype and psychosis | Q73214736 | ||
| Apolipoprotein E epsilon4 and tardive dyskinesia in a Japanese population | Q73265758 | ||
| Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features | Q73389055 | ||
| Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia | Q73532904 | ||
| Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination | Q73625774 | ||
| Apolipoprotein E epsilon2 allele and early onset schizophrenia | Q73655862 | ||
| Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia | Q73742672 | ||
| Apolipoprotein E epsilon4 allele and schizophrenia | Q74032360 | ||
| Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia | Q74036493 | ||
| Apolipoprotein E genotype and schizophrenia: further negative evidence | Q74370537 | ||
| No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients | Q74459066 | ||
| Apolipoprotein E alleles in childhood-onset schizophrenia | Q77333726 | ||
| P433 | issue | 1 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 18-23 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | Q15762380 |
| P1476 | title | Apolipoprotein E in schizophrenia: a French association study and meta-analysis | |
| P478 | volume | 119B |
| Q34266990 | A re-review of the association between the NOTCH4 locus and schizophrenia |
| Q47279847 | Apolipoprotein E polymorphism is associated with age of onset in schizophrenia |
| Q35992151 | Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis |
| Q33246888 | Bioactive lipids in schizophrenia |
| Q48339668 | Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients |
| Q43072099 | Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls |
| Q47829678 | Genome-wide linkage scan of schizophrenia: a cross-isolate study. |
| Q22252612 | Is There Evidence for Late Cognitive Decline in Chronic Schizophrenia? |
Search more.